Cite
[Therapeutic decisions and treatment with sorafenib in hepatocellular carcinoma: final analysis of GIDEON study in Italy].
MLA
D’Angelo, Salvatore, et al. “[Therapeutic Decisions and Treatment with Sorafenib in Hepatocellular Carcinoma: Final Analysis of GIDEON Study in Italy].” Recenti Progressi in Medicina, vol. 106, no. 5, May 2015, pp. 217–26. EBSCOhost, https://doi.org/10.1701/1868.20406.
APA
D’Angelo, S., Germano, D., Zolfino, T., Sansonno, D., Giannitrapani, L., Benedetti, A., Montesarchio, V., Attili, A., Buonadonna, A., Barni, S., Gasbarrini, A., Burlone, M. E., Cillo, U., Marenco, S., Villa, E., Giovanis, P., Proserpio, I., Saitta, C., Magini, G., … Lorusso, V. (2015). [Therapeutic decisions and treatment with sorafenib in hepatocellular carcinoma: final analysis of GIDEON study in Italy]. Recenti Progressi in Medicina, 106(5), 217–226. https://doi.org/10.1701/1868.20406
Chicago
D’Angelo, Salvatore, Domenico Germano, Teresa Zolfino, Domenico Sansonno, Lydia Giannitrapani, Antonio Benedetti, Vincenzo Montesarchio, et al. 2015. “[Therapeutic Decisions and Treatment with Sorafenib in Hepatocellular Carcinoma: Final Analysis of GIDEON Study in Italy].” Recenti Progressi in Medicina 106 (5): 217–26. doi:10.1701/1868.20406.